Skip to main content
. 2015 Sep 29;2(2):153–164. doi: 10.1007/s40744-015-0019-6

Table 3.

Estimated median months from Corrona RA registry enrollment to first drug use among patients with no identified RA-directed therapy at time of enrollment (N = 750)

Therapy initiation n (%) Median time in months (95% CI)
Any drug use
Prednisone, MTX, nbDMARD, or biologic 372 (49.6%) 12.1 (9.3–14.8)
First steroid or DMARD use
Prednisone, MTX, or nbDMARD 354 (47.2%) 14.5 (11.3–17.1)
First DMARD use excluding steroids
MTX or nbDMARD 325 (43.3%) 15.9 (12.2–18.4)